In a groundbreaking genetic analysis, researchers from Australia’s QIMR Berghofer Medical Research Institute have uncovered compelling evidence that women carry a heavier genetic burden for depression compared to men, potentially reshaping how we understand and treat this pervasive mental health challenge.
For decades, mental health experts have observed that women experience depression at roughly twice the rate of men, but the underlying reasons have remained elusive. Now, a massive study published in Nature Communications described as one of the largest of its kind has pinpointed DNA as a key culprit. By scrutinizing the genomes of nearly 200,000 individuals diagnosed with major depressive disorder, the team identified thousands of genetic variants that heighten vulnerability. Strikingly, women harbored almost double the number of these markers linked to the condition.
The dataset included DNA from approximately 130,000 women and 65,000 men, all confirmed cases of major depression. Lead investigator Jodi Thomas, a neuro-geneticist at QIMR Berghofer, emphasized the disparity: “The genetic component to depression is larger in females compared to males.” She noted that teasing apart these shared and sex-specific factors not only clarifies the roots of depression but also paves the way for tailored therapies that address individual biology more precisely.
Overall, scientists flagged about 7,000 DNA alterations associated with major depressive disorder across both sexes, alongside roughly 6,000 additional variants that appeared to trigger the disorder exclusively in women. The study also illuminated how the illness manifests differently: Women often grapple with symptoms like weight gain, heightened appetite, and excessive daytime sleepiness, tied to disruptions in metabolic and hormonal pathways. Men, by contrast, tend to exhibit outward expressions such as anger, aggression, risky behaviors, and substance misuse.
ALSO READ : Diwali 2025: Kitchen items to get rid of that are silently harming your health
Thomas elaborated on these insights, stating, “We found some genetic differences that may help explain why females with depression more often experience metabolic symptoms, such as weight changes or altered energy levels.” Co-researcher Brittany Mitchell highlighted the study’s implications for clinical practice: “Until now, there hasn’t been much consistent research to explain why depression affects females and males differently, including the possible role of genetics.” She pointed out a critical gap in current approaches: “There are more and more stories coming out about how many of the medications that are currently developed, and the research that we’ve known to date, have mostly been focused on men or male participants.”
This revelation arrives amid a global crisis, as the World Health Organisation estimates that over 300 million people worldwide live with clinical depression, the most prevalent mental disorder. By spotlighting these genetic nuances, the findings from QIMR Berghofer could spur more equitable, sex-sensitive interventions offering hope for the millions disproportionately affected.
-
-
-
-
